Abolis is a startup based in Germany, most recent round Seed, 1 tracked investor.
Based in Germany, Abolis is a startup founded in 2019. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Abolis is a synthetic biology company that develops and produces sustainable ingredients for various industries. They leverage cutting-edge synthetic biology and metabolic engineering to create novel microbial strains for high-value compounds.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.